Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Solicitation (Request for proposal) from Barda - Aspr / Daappo / Barda Dcma. This notice has closed.

Open to all (no set-aside)Any registered business can bid, large or small.Who qualifies
  • ClosedDays left to respond
  • 1827 daysThis buyer usually gives
  • 13%Notices this buyer changes
  • $86.8MTypical award from this office

What BidCamel found about this buyer

  • This office usually gives bidders 1827 days to respond; this notice gives 95 days.
  • It changed 13% of its 8 notices after posting, so check for amendments before you submit.
  • It has 5 open bids right now. See them all.
  • It has made 1 awards in our records, typically $86.8M.

Companies this office paid before

  • Contrafect Corporation: 1 award, $86.8M total

These are past winners at this office, not the winner of this exact contract.

Key details
Solicitation number
75A50126R00001_RFP_NPIVS_27
NAICS code
541714 Research and Development in Biotechnology (except
Size standard for this code
1,000 employees
Set-aside
Open to all (no set-aside)
Buying
Service
Place
Washington, DC · District of Columbia bids
Posted
Aug 17, 2026
Last changed
Oct 26, 2026 (4 versions)
Contact
Contact details are on the SAM.gov notice. Open on SAM.gov

Description

BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods. Mandatory Qualification Requirements: To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by: 1. Holding a U.S. influenza vaccine license; or 2. Have developed an influenza vaccine as evidenced by: a. Submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine Please see full solicitation details and proposal submission instructions detailed in attachments 01-21 of this notice.

Read the full notice and attachments on SAM.gov

Similar open bids

All open bids for NAICS 541714

From SAM.gov and USAspending.gov public data. BidCamel adds the buyer and award facts.